After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted Cronos Launches Lord Jones® Chocolate Fusions.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, CRON falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Cronos Group Inc is $949.44M. A total of 6.31 million shares were traded on the day, compared to an average of 2.38M shares.
In the most recent transaction, ADLER JASON MARC bought 37,500 shares of CRON for 1.74 per share on May 30 ’23. After the transaction, the Director now owns 1,402,304 company shares. In a previous transaction on May 25 ’23, ADLER JASON MARC bought 100,000 shares at 1.80 per share. CRON shares that Director owns now total 1,376,054.
Among the insiders who bought shares, ADLER JASON MARC acquired of 100,000 shares on May 23 ’23 at a per-share price of $1.90. This resulted in the Director holding 1,306,055 shares of CRON after the transaction. In another insider transaction, ADLER JASON MARC bought 100,000 shares at $1.89 per share on May 19 ’23. Company shares held by the Director now total 1,236,056.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRON has a high of $2.64 and a low of $1.64.
As of this writing, CRON has an earnings estimate of -$0.01 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.01. The company reported an EPS of $0 in the last quarter, which was 100.00% higher than expectations of -$0.02.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRON’s latest balance sheet shows that the firm has $1.00B in Cash & Short Term Investments as of fiscal 2021. There were $9.81M in debt and $54.37M in liabilities at the time. Its Book Value Per Share was $2.88, while its Total Shareholder’s Equity was $1.33B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRON is Buy with a score of 3.63.
